Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population.

DNA and cell biology - 1 May 2006

Sobti R C, Onsory Khadijeh, Al-Badran Adnan Issa, Kaur Pushpinder, Watanabe Masatoshi, Krishan A, Mohan Harsh

Abstract excerpt

To investigate the involvement of the CYP17, SRD5A2, CYP1B1, and CYP2D6 variants with prostate cancer, a case-control study of 100 patients and an equal number of age-matched control men was conducted. There appears to be a nonsignificant increase with risk of prostate cancer for individuals carrying one copy of the CYP17 A2 allele (OR, 1.80; 95% CI, 0.99-3.29, P=0.05). The risk was increased in individuals...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to DNA Primers

Share to Heterozygote

Share to Homozygote

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 16716118
DOI: 10.1089/dna.2006.25.287

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population.PMID 16716118Read ↗

The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.Semantic proximity Read ↗

Role of hormonal genes and risk of prostate cancer: gene-gene interactions in a North Indian population.Semantic proximity Read ↗

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).Semantic proximity Read ↗

Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk.Semantic proximity Read ↗

Cytochrome p4501A1 gene variants as susceptibility marker for prostate cancer.Semantic proximity Read ↗

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.Semantic proximity Read ↗

Genetic polymorphism in sex hormone metabolism and prostate cancer risk.Semantic proximity Read ↗

Prostate cancer with variants in CYP17 and UGT2B17 genes: a meta-analysis.Semantic proximity Read ↗

Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.Semantic proximity Read ↗

Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer.Semantic proximity Read ↗

CYP17 gene polymorphism and its association in north Indian prostate cancer patients.Semantic proximity Read ↗

The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.